End-to-end solution in psychedelic therapies establishes Numinus as leader in emerging space Pharmaceutical Investing
Algernon Pharmaceuticals Announces Increase and Closing of CDN$1.55M Private Placement Pharmaceutical Investing
FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech Cannabis Investing News
Algernon Pharmaceuticals Appoints Professor of Respiratory Medicine Dr. Jacky Smith to Its Medical and Scientific Advisory Board Biotech Investing
FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC Cannabis Investing News
